Emtricitabine Completed Phase 1 Trials for HIV Prevention Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT03270969A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women